# Interest of S100B Protein for Patient Victim of Minor Traumatic Brain Injury and Treated by Antiplatelet

> **NCT03780062** · PHASE3 · COMPLETED · sponsor: **Poitiers University Hospital** · enrollment: 720 (actual)

## Conditions studied

- Minor Traumatic Brain Injury
- Treatment by Antiplatelet

## Interventions

- **BIOLOGICAL:** S100B protein dosing

## Key facts

- **NCT ID:** NCT03780062
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-25
- **Primary completion:** 2025-04-28
- **Final completion:** 2025-10-28
- **Target enrollment:** 720 (ACTUAL)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03780062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03780062, "Interest of S100B Protein for Patient Victim of Minor Traumatic Brain Injury and Treated by Antiplatelet". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03780062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*